Halozyme Therapeutics (RV7.F) Q3 2025 Earnings

Aug 5Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
0.81
0.99
1.16
1.33

Details

Expected EPS
1.09554799541
Actual EPS
1.3302058
Surprise EPS
0.23
Surprise Percent
+21.42%

Description

⁨Halozyme Therapeutics⁩ (⁦RV7.F⁩) has reported earnings of ⁦1.3302058⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts